NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Archeus Technologies

Archeus Technologies

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.archeustech.com/

Last Round

Grant

Feb 3, 2026

Total Funding Raised

$50,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Archeus Technologies is a clinical-stage radiopharmaceutical company developing therapies for difficult-to-treat cancers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceutical therapiesRPTstargeted radionuclide therapiesTRTtheranosticssmall-molecule therapiescompanion diagnosticsclinical-stage biopharmaprostate cancer treatmentPSMA-targeting agentprecision medicinenuclear medicineoncology therapeuticsdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Archeus Technologies Comparables

Compare Archeus Technologies with similar companies based on industry and business-model similarity.

Archeus Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Archeus Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2026
AcceleratorAug 21, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Evan Sengbusch

CEO, Board Member

Executive Team

Reinier Hernandez

Chief Technology Officer

Executive Team

Archeus Technologies Investors

Notable investors and investment history

Archeus Technologies investors
InvestorRounds
Isthmus ProjectAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    $50K grant received from Forward BIOLABS.

  • Jul 22, 2025

    Grew 75% QoQ from 4 to 7 employees.

View all signals

Archeus Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Archeus Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Archeus Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range7
Year Founded2016
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.